2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …

G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Factor XI Inhibition to Uncouple Thrombosis From Hemostasis: JACC Review Topic of the Week

C Hsu, E Hutt, DM Bloomfield, D Gailani… - Journal of the American …, 2021 - jacc.org
Hemostasis and thrombosis are believed to be so intricately linked that any strategies that
reduce thrombosis will have an inevitable impact on hemostasis. Consequently, bleeding is …

Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report

GYH Lip, A Banerjee, G Boriani, C en Chiang, R Fargo… - Chest, 2018 - Elsevier
Background The risk of stroke is heterogeneous across different groups of patients with atrial
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …

Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients: the ARISTOPHANES study

GYH Lip, A Keshishian, X Li, M Hamilton, C Masseria… - Stroke, 2018 - Am Heart Assoc
Background and Purpose—This ARISTOPHANES study (Anticoagulants for Reduction in
Stroke: Observational Pooled Analysis on Health Outcomes and Experience of Patients) …

Stroke prevention in atrial fibrillation: past, present and future

GYH Lip, B Freedman, R De Caterina… - Thrombosis and …, 2017 - thieme-connect.com
Concepts and our approaches to stroke prevention in atrial fibrillation (AF) have changed
markedly over the last decade. There has been an evolution over the approach to stroke and …

Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: A nationwide propensity score–weighted study

AB Ingason, JP Hreinsson, AS Ágústsson… - Annals of Internal …, 2021 - acpjournals.org
Background: Gastrointestinal bleeding (GIB) rates for direct oral anticoagulants (DOACs)
and warfarin have been extensively compared. However, population-based studies …

Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document …

B Gorenek, J Bax, G Boriani, SA Chen, N Dagres… - Ep …, 2017 - academic.oup.com
Among atrial tachyarrhythmias (AT), atrial fibrillation (AF) is the most common sustained
arrhythmia. Many patients with AT have no symptoms during brief or even extended periods …

Real-world use of apixaban for stroke prevention in atrial fibrillation: a systematic review and meta-analysis

M Proietti, I Romanazzi, GF Romiti, A Farcomeni… - Stroke, 2018 - Am Heart Assoc
Background and Purpose—The use of oral anticoagulant therapy for stroke prevention in
atrial fibrillation has been transformed by the availability of the nonvitamin K antagonist oral …

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation

MJ Cha, EK Choi, KD Han, SR Lee, WH Lim, S Oh… - Stroke, 2017 - Am Heart Assoc
Background and Purpose—There are limited real-world data comparing the effectiveness
and safety of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in Asians …

Management of atrial high-rate episodes detected by cardiac implanted electronic devices

B Freedman, G Boriani, TV Glotzer, JS Healey… - Nature Reviews …, 2017 - nature.com
Cardiac implanted electronic devices (CIEDs), including pacemakers and implantable
defibrillators that perform atrial sensing typically using an atrial electrode, frequently detect …